Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yodoi

Showing results (221-230 of 269) with videos related to

Pageof 27
Sort By:
Blood|June 1, 1986
Induction of Tac antigen and proliferation of myeloid leukemic cells by ATL-derived factor: comparison with other agents that promote differentiation of human myeloid or monocytic leukemic cellsS Yamamoto, T Hattori, M Matsuoka, et al.
Molecular Immunology|February 1, 1992
Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agentA Yamauchi, H Masutani, Y Tagaya, et al.
Biochemical and Biophysical Research Communications|March 13, 1987
Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analoguesS Narumiya, M Hirata, T Nanba, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 1998
Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteriesY Takagi, Y Gon, T Todaka, et al.
Biochemical and Biophysical Research Communications|July 25, 2000
Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cellsK Hirota, M Matsui, M Murata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1988
IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factorY Tagaya, M Okada, K Sugie, et al.
Cancer Research|October 1, 1995
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposideA Yokomizo, M Ono, H Nanri, et al.
Oncogene|November 30, 2005
Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2M K Ahsan, H Masutani, Y Yamaguchi, et al.
Immunology Letters|September 1, 1994
Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxideH Nakamura, M Matsuda, K Furuke, et al.
Molecular Biology & Medicine|December 1, 1984
Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfectionH Sabe, S Kondo, A Shimizu, et al.
Pageof 27

Showing results (221-230 of 269) with videos related to

Sort By:
Pageof 27
Blood|June 1, 1986
Induction of Tac antigen and proliferation of myeloid leukemic cells by ATL-derived factor: comparison with other agents that promote differentiation of human myeloid or monocytic leukemic cellsS Yamamoto, T Hattori, M Matsuoka, et al.
Molecular Immunology|February 1, 1992
Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agentA Yamauchi, H Masutani, Y Tagaya, et al.
Biochemical and Biophysical Research Communications|March 13, 1987
Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analoguesS Narumiya, M Hirata, T Nanba, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 1998
Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteriesY Takagi, Y Gon, T Todaka, et al.
Biochemical and Biophysical Research Communications|July 25, 2000
Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cellsK Hirota, M Matsui, M Murata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1988
IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factorY Tagaya, M Okada, K Sugie, et al.
Cancer Research|October 1, 1995
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposideA Yokomizo, M Ono, H Nanri, et al.
Oncogene|November 30, 2005
Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2M K Ahsan, H Masutani, Y Yamaguchi, et al.
Immunology Letters|September 1, 1994
Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxideH Nakamura, M Matsuda, K Furuke, et al.
Molecular Biology & Medicine|December 1, 1984
Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfectionH Sabe, S Kondo, A Shimizu, et al.
Pageof 27